← FDA Drug Approvals (Drugs@FDA)

DAPTOMYCIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: XELLIA PHARMS APS · Approved 2016-06-15

Drug application

FDA Application #

ANDA206005

Application type

Abbreviated New Drug Application (Generic)

Brand name

DAPTOMYCIN

Generic name

DAPTOMYCIN

Active ingredients

DAPTOMYCIN

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

XELLIA PHARMS APS

Manufacturer

Hikma Pharmaceuticals USA Inc.

First approval

2016-06-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown